Entyvio for Subcutaneous Use Approved for Maintenance in Crohn Disease
The approval was based on data from the phase 3 VISIBLE 2 trial.
The approval was based on data from the phase 3 VISIBLE 2 trial.
Designed for digitization, distance health, discovery and more
This cohort study assesses the risk of cancer, overall and by cancer type, among children born after medically assisted reproduction compared with children conceived naturally.
Big systemic changes are needed to successfully address the nation’s maternal health crisis. Learn more with the AMA.
When treated with a novel protein function inhibitor called ESI1, mice that mimic the symptoms of multiple sclerosis (MS) and lab-prepared human brain cells both…
Researchers at UBC and BC Cancer have developed a new artificial intelligence (AI) model that can accurately predict if a person receiving cancer care will…
An experimental influenza vaccine carrying more than 80,000 variations of hemagglutinin antigens caused the immune system of mice and ferrets to respond more strongly to…
Background Studying individuals with varying symptoms, from mild to severe, can provide valuable insights into the spectrum of cognitive outcomes after COVID-19. We investigated the…
Contract research firm IQVIA Holdings lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched…
The test would determine if patients are eligible for Pfizer’s new hemophilia B treatment by detecting if they have been exposed to a virus that…
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company…